Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | -4.59% |
|
-7.85% | +82.43% |
02/05 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.43% | 12Cr | |
+40.80% | 5.37TCr | |
+35.79% | 3.89TCr | |
-8.05% | 3.88TCr | |
-8.98% | 2.73TCr | |
+10.69% | 2.59TCr | |
-16.21% | 2.03TCr | |
+31.00% | 1.28TCr | |
+28.51% | 1.22TCr | |
-1.67% | 1.2TCr |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- HC Wainwright Adjusts Cardiff Oncology's Price Target to $25 from $26, Keeps Buy Rating